In a microdosing study, subpharmacologically active doses of drug are given to human volunteers at an early stage of development in order to obtain preliminary pharmacokinetic data. The very low doses of drug administered (≤100 µg) consequently lead to very low concentrations of drug appearing in the body and therefore highly sensitive analytical techniques are required. There are three such analytical technologies currently used in microdosing studies: PET, liquid chromatography (LC)-tandem mass spectrometry (MS/MS) and accelerator mass spectrometry (AMS). Both PET and AMS employ radioisotopic tracers. PET is an imaging technique and AMS is an extremely sensitive isotope ratio method, able to measure drug concentrations in the ag/ml range....
A comparison has been made between accelerator mass spectrometry (AMS) analysis and liquid scintilla...
Microdosing, or human phase 0 clinical trials, is a technique whereby subpharmacological doses of pr...
A comparison has been made between accelerator mass spectrometry (AMS) analysis and liquid scintilla...
In a microdosing study, subpharmacologically active doses of drug are given to human volunteers at a...
Microdosing is a new concept in drug development that-if implemented in the pharmaceutical industry-...
The process of early clinical drug development has changed little over the past 20 years despite an ...
The phase O microdosing concept was introduced recently by the FDA in order to shorten the timeline ...
A decreasing number of new therapeutic drugs reaching the clinic has led to the publication of regul...
The technique of accelerator mass spectrometry (AMS) was vali-dated successfully and used to study t...
Positron emission tomography (PET) imaging using microdoses of radiolabeled drug tracers is gaining ...
The concept of microdosing has been around for approximately 10 years. In this time there have been ...
There is an increasing recognition within the pharmaceutical industry of the importance of the ADME ...
Liquid chromatography – mass spectrometry (LC-MS) methods were developed for the analysis of positro...
Introduction: Microdosing is an approach to early drug development where exploratory pharmacokinetic...
INTRODUCTION: Microdosing is an approach to early drug development where exploratory pharmacokinetic...
A comparison has been made between accelerator mass spectrometry (AMS) analysis and liquid scintilla...
Microdosing, or human phase 0 clinical trials, is a technique whereby subpharmacological doses of pr...
A comparison has been made between accelerator mass spectrometry (AMS) analysis and liquid scintilla...
In a microdosing study, subpharmacologically active doses of drug are given to human volunteers at a...
Microdosing is a new concept in drug development that-if implemented in the pharmaceutical industry-...
The process of early clinical drug development has changed little over the past 20 years despite an ...
The phase O microdosing concept was introduced recently by the FDA in order to shorten the timeline ...
A decreasing number of new therapeutic drugs reaching the clinic has led to the publication of regul...
The technique of accelerator mass spectrometry (AMS) was vali-dated successfully and used to study t...
Positron emission tomography (PET) imaging using microdoses of radiolabeled drug tracers is gaining ...
The concept of microdosing has been around for approximately 10 years. In this time there have been ...
There is an increasing recognition within the pharmaceutical industry of the importance of the ADME ...
Liquid chromatography – mass spectrometry (LC-MS) methods were developed for the analysis of positro...
Introduction: Microdosing is an approach to early drug development where exploratory pharmacokinetic...
INTRODUCTION: Microdosing is an approach to early drug development where exploratory pharmacokinetic...
A comparison has been made between accelerator mass spectrometry (AMS) analysis and liquid scintilla...
Microdosing, or human phase 0 clinical trials, is a technique whereby subpharmacological doses of pr...
A comparison has been made between accelerator mass spectrometry (AMS) analysis and liquid scintilla...